The initial analyses of our study reveal the psychometric robustness of the DMQ when used as a global score.
The initial analyses outlined above show how one practice can prefigure another practice through particular practice architectures.
The initial analyses revealed excellent gene colinearity both in their physical maps [50] and in sequence comparisons [96].
Nine additional genes showed up and downregulation in the same direction as what was found in the initial analyses compared to the initial analyses.
Each collection site was operationally treated as a population (gene pool) for the initial analyses.
To extend the initial analyses to all DE genes, we performed GO enrichment (Table 2).
Six additional genes showed up and downregulation in the same direction as what was found in the initial analyses.
Eight genes showed up and downregulation in the same direction as what was found in the initial analyses.
The initial analyses were based on two mitochondrial genes: cytochrome oxidase I (cox1) and cytochrome b (cob).
The eight genes had coherent up and downregulation in the respective clinical groups compared to the initial analyses.
The initial analyses in this study were performed using a biochip immunoassay system from the same manufacturer (Randox Laboratories Ltd) as in the Asberg study [11].
